Detalles de la búsqueda
1.
Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis.
Clin Infect Dis
; 2022 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35767251
2.
The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB.
Trop Med Infect Dis
; 8(8)2023 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37624349
3.
Experience of "One Stop TB Diagnostic Solution" Model in Engaging a Private Laboratory for End-to-End Diagnostic Services in the National TB Elimination Program in Hisar, India.
Diagnostics (Basel)
; 13(17)2023 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37685361
4.
Comprehensive assessment of invalid and indeterminate results in Truenat MTB-RIF testing across sites under the national TB elimination program of India.
Front Public Health
; 11: 1255756, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37886056
5.
Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.
PLoS One
; 10(5): e0126065, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25996389
6.
Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
PLoS One
; 9(8): e105346, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25140877
7.
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.
PLoS One
; 9(2): e89301, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24586675
Resultados
1 -
7
de 7
1
Próxima >
>>